Ann Lab Med.  2019 Jan;39(1):102-104. 10.3343/alm.2019.39.1.102.

Planned Transfusion of D-Positive Blood Components in an Asia Type DEL Patient: Proposed Modification of the Korean National Guidelines for Blood Transfusion

Affiliations
  • 1Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. duck.cho@skku.edu
  • 2Department of Laboratory Medicine, Chonnam National University Medical School & Hospital, Gwangju, Korea.
  • 3Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

Abstract

No abstract available.


MeSH Terms

Asia*
Blood Transfusion*
Humans

Figure

  • Fig. 1 Comparison of Korean National Guidelines for Blood Transfusion and our suggested policy for blood transfusion in Asia type DEL patients. (A) According to the Korean National Guidelines for Blood Transfusion (revised in 2016), Asia type DEL is regarded as D-negative, and patients can receive D-positive blood in only emergency situations or a D-negative blood shortage. (B) In our proposed policy, an Asia type DEL patient receives D-positive blood without delay in both emergency and non-emergency situations.


Cited by  2 articles

A Case of Partial D Type VI-3 Confirmed by RHD Genotyping
Jong Kwon Lee, HongBi Yu, Yoo Na Chung, Jae Chun Bae,, Duck Cho
Lab Med Online. 2020;10(4):326-329.    doi: 10.47429/lmo.2020.10.4.326.

Guide to Rho(D) Immune Globulin in Women With Molecularly Defined Asian-type DEL (c.1227G>A)
In Hwa Jeong, SooHo Yu, Tae Yeul Kim, Soo-Young Oh, Duck Cho
Ann Lab Med. 2024;44(4):307-313.    doi: 10.3343/alm.2023.0356.


Reference

1. Seo MH, Won EJ, Hong YJ, Chun S, Kwon JR, Choi YS, et al. An effective diagnostic strategy for accurate detection of RhD variants including Asian DEL type in apparently RhD-negative blood donors in Korea. Vox Sang. 2016; 111:425–430. PMID: 27864976.
2. Shao CP. Transfusion of RhD-positive blood in “Asia type” DEL recipients. N Engl J Med. 2010; 362:472–473. PMID: 20130261.
3. Wagner FF, Frohmajer A, Flegel WA. RHD positive haplotypes in D negative Europeans. BMC Genet. 2001; 2:10. PMID: 11495631.
4. Korea Centers for Disease Control and Prevention. Korean National Transfusion Guideline. 4th ed. Osong: Korea Centers for Disease Control and Prevention;2016. p. 15–16.
5. Park JY, Cho D, Choi HW, Jeon MJ, Park MS, Song JW, et al. A patient with RhDel (1227G>A) failed to produce detectable anti-D after transfusion of RhD positive red blood cells. Korean J Blood Transfus. 2006; 17:153–158.
6. Kormoczi GF, Gassner C, Shao CP, Uchikawa M, Legler TJ. A comprehensive analysis of DEL types: partial DEL individuals are prone to anti-D alloimmunization. Transfusion. 2005; 45:1561–1567. PMID: 16181205.
7. Xu W, Zhu M, Wang BL, Su H, Wang M. Prospective evaluation of a transfusion policy of rhd-positive red blood cells into DEL patients in China. Transfus Med Hemother. 2015; 42:15–21. PMID: 25960711.
8. Gardener GJ, Legler TJ, Hyett JA, Liew YW, Flower RL, Hyland CA. Anti-D in pregnant women with the RHD(IVS3+1G>A)-associated DEL phenotype. Transfusion. 2012; 52:2016–2019. PMID: 22313164.
9. Richard M, Perreault J, Constanzo-Yanez J, Khalife S, St-Louis M. A new DEL variant caused by exon 8 deletion. Transfusion. 2007; 47:852–857. PMID: 17465950.
Full Text Links
  • ALM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr